Collecting data on childhood cancer patients
Protocol For Collecting Data On Patients With Childhood Cancer
This study is trying to gather important long-term health information from children who have been treated for cancer to help improve their care and monitor any lasting effects.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 30000 (estimated) |
| Sex | All |
| Sponsor | St. Jude Children's Research Hospital Academic / other |
| Locations | 1 site (Memphis, Tennessee) |
| Trial ID | NCT00684580 on ClinicalTrials.gov |
What this trial studies
This protocol aims to centralize the collection of long-term follow-up data on patients treated for childhood cancer at St. Jude Children's Research Hospital. It focuses on monitoring late treatment effects and outcomes for both current and former patients. By establishing a coordinated approach to data collection, the study seeks to enhance communication regarding late toxicities and improve preventive care for survivors. Data will be gathered from clinical encounters and follow-up forms provided by patients or their families.
Who should consider this trial
Good fit: Ideal candidates include all patients currently being treated or followed for childhood cancer at St. Jude.
Not a fit: Patients who are permanently discharged from care or only receiving consultative services at St. Jude will not benefit from this study.
Why it matters
Potential benefit: If successful, this initiative could lead to improved monitoring and management of late effects in childhood cancer survivors.
How similar studies have performed: Other studies have successfully implemented centralized data collection for monitoring late effects in cancer survivors, indicating a promising approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * All St Jude patients actively being followed or treated for childhood cancer Exclusion Criteria: * St. Jude consult only patients * St. Jude patients permanently discharged from care and follow-up Permanently discharged patients include patients who have electively transferred their oncologic care to another institution, those who are noncompliant with recommended follow-up or those leaving the institution against medical advice. * Patients referred to St. Jude for limited care on phase 1 protocol.
Where this trial is running
Memphis, Tennessee
- St. Jude Children's Research Hospital — Memphis, Tennessee, United States (Recruiting)
Study contacts
- Principal investigator: Melissa M Hudson, MD — St. Jude Children's Research Hospital
- Study coordinator: Melissa M Hudson, MD
- Email: referralinfo@stjude.org
- Phone: 888-226-4343
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.